Parkman Healthcare Partners’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.25M | Sell |
500,000
-543,162
| -52% | -$3.53M | 0.37% | 69 |
|
|
2025
Q1 | $8.27M | Buy |
1,043,162
+42,688
| +4% | +$339K | 0.98% | 38 |
|
|
2024
Q4 | $12.7M | Buy |
1,000,474
+76,334
| +8% | +$967K | 1.69% | 21 |
|
|
2024
Q3 | $12.9M | Buy |
924,140
+15,318
| +2% | +$213K | 1.64% | 21 |
|
|
2024
Q2 | $12.5M | Buy |
908,822
+217,010
| +31% | +$2.99M | 1.68% | 18 |
|
|
2024
Q1 | $11.4M | Buy |
691,812
+66,063
| +11% | +$1.09M | 1.4% | 27 |
|
|
2023
Q4 | $9.14M | Buy |
625,749
+159,341
| +34% | +$2.33M | 1.29% | 26 |
|
|
2023
Q3 | $5.72M | Buy |
466,408
+38,129
| +9% | +$468K | 1.05% | 31 |
|
|
2023
Q2 | $5.11M | Buy |
428,279
+28,059
| +7% | +$335K | 0.89% | 35 |
|
|
2023
Q1 | $5.35M | Buy |
400,220
+175,737
| +78% | +$2.35M | 1.16% | 34 |
|
|
2022
Q4 | $4.83M | Buy |
224,483
+12,292
| +6% | +$265K | 1.29% | 28 |
|
|
2022
Q3 | $4.25M | Buy |
212,191
+97,441
| +85% | +$1.95M | 1.21% | 26 |
|
|
2022
Q2 | $2.05M | Buy |
+114,750
| New | +$2.05M | 0.76% | 43 |
|